BIOMAT Database Logo BIOMAT Database Logo

[Immunologic observations on the primary and secondary treatment of diabetics with human insulin]. 1983

K Federlin, and H Laube, and E Mäser, and H G Velcowsky

UI MeSH Term Description Entries
D007074 Immunoglobulin G The major immunoglobulin isotype class in normal human serum. There are several isotype subclasses of IgG, for example, IgG1, IgG2A, and IgG2B. Gamma Globulin, 7S,IgG,IgG Antibody,Allerglobuline,IgG(T),IgG1,IgG2,IgG2A,IgG2B,IgG3,IgG4,Immunoglobulin GT,Polyglobin,7S Gamma Globulin,Antibody, IgG,GT, Immunoglobulin
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D003920 Diabetes Mellitus A heterogeneous group of disorders characterized by HYPERGLYCEMIA and GLUCOSE INTOLERANCE.
D004926 Escherichia coli A species of gram-negative, facultatively anaerobic, rod-shaped bacteria (GRAM-NEGATIVE FACULTATIVELY ANAEROBIC RODS) commonly found in the lower part of the intestine of warm-blooded animals. It is usually nonpathogenic, but some strains are known to produce DIARRHEA and pyogenic infections. Pathogenic strains (virotypes) are classified by their specific pathogenic mechanisms such as toxins (ENTEROTOXIGENIC ESCHERICHIA COLI), etc. Alkalescens-Dispar Group,Bacillus coli,Bacterium coli,Bacterium coli commune,Diffusely Adherent Escherichia coli,E coli,EAggEC,Enteroaggregative Escherichia coli,Enterococcus coli,Diffusely Adherent E. coli,Enteroaggregative E. coli,Enteroinvasive E. coli,Enteroinvasive Escherichia coli
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000918 Antibody Specificity The property of antibodies which enables them to react with some ANTIGENIC DETERMINANTS and not with others. Specificity is dependent on chemical composition, physical forces, and molecular structure at the binding site. Antibody Specificities,Specificities, Antibody,Specificity, Antibody
D001426 Bacterial Proteins Proteins found in any species of bacterium. Bacterial Gene Products,Bacterial Gene Proteins,Gene Products, Bacterial,Bacterial Gene Product,Bacterial Gene Protein,Bacterial Protein,Gene Product, Bacterial,Gene Protein, Bacterial,Gene Proteins, Bacterial,Protein, Bacterial,Proteins, Bacterial

Related Publications

K Federlin, and H Laube, and E Mäser, and H G Velcowsky
[Treatment of diabetics with human-type insulin].
January 1984, Minerva endocrinologica,
K Federlin, and H Laube, and E Mäser, and H G Velcowsky
Treatment with human insulin in out patient diabetics.
July 1982, Lancet (London, England),
K Federlin, and H Laube, and E Mäser, and H G Velcowsky
Observations with Insulin on Department of Soldiers' Civil Re-Establishment Diabetics.
August 1923, Canadian Medical Association journal,
K Federlin, and H Laube, and E Mäser, and H G Velcowsky
Observations on the intensive treatment of incipient, primary and secondary syphilis.
January 1947, Revista medica de Costa Rica,
K Federlin, and H Laube, and E Mäser, and H G Velcowsky
[Doses of biogenetic human insulin for the treatment of diabetics with anti-insulin antibodies].
November 1985, Presse medicale (Paris, France : 1983),
K Federlin, and H Laube, and E Mäser, and H G Velcowsky
[Primary and secondary immunologic response].
January 1970, Postepy higieny i medycyny doswiadczalnej,
K Federlin, and H Laube, and E Mäser, and H G Velcowsky
[CLINICAL OBSERVATIONS ON THE TREATMENT OF DIABETES MELLITUS WITH HUMAN GLOBIN INSULIN].
April 1965, Minerva medica,
K Federlin, and H Laube, and E Mäser, and H G Velcowsky
[Recrystallized insulin in the treatment of diabetics with insulin allergy].
August 1951, Il Policlinico. Sezione pratica,
K Federlin, and H Laube, and E Mäser, and H G Velcowsky
Effects of insulin therapy on non-insulin-dependent diabetics with secondary oral hypoglycemic agent failure.
September 1998, Changgeng yi xue za zhi,
K Federlin, and H Laube, and E Mäser, and H G Velcowsky
Observations on a chemical treatment of primary and secondary carcinoma of the vagina.
January 1952, Acta - Unio Internationalis Contra Cancrum,
Copied contents to your clipboard!